For: | Liu DY, Peng ZH, Qiu GQ, Zhou CZ. Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis. World J Gastroenterol 2003; 9(8): 1859-1862 [PMID: 12918139 DOI: 10.3748/wjg.v9.i8.1859] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i8/1859.htm |
Number | Citing Articles |
1 |
O M Wolkowitz, S H Mellon, E S Epel, J Lin, V I Reus, R Rosser, H Burke, M Compagnone, J C Nelson, F S Dhabhar, E H Blackburn. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Molecular Psychiatry 2012; 17(2): 164 doi: 10.1038/mp.2010.133
|
2 |
F. Berardinelli, A. Antoccia, R. Cherubini, V. De Nadal, S. Gerardi, G. A. P. Cirrone, C. Tanzarella, A. Sgura. Transient Activation of the ALT Pathway in Human Primary Fibroblasts Exposed to High-LET Radiation. Radiation Research 2010; 174(5): 539 doi: 10.1667/RR2127.1
|
3 |
Taichiro Nishikawa, Tomoki Nakajima, Tatsuo Katagishi, Yoshihisa Okada, Masayasu Jo, Keizo Kagawa, Takeshi Okanoue, Yoshito Itoh, Toshikazu Yoshikawa. Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation. Liver International 2009; 29(6): 846 doi: 10.1111/j.1478-3231.2008.01963.x
|
4 |
José C.R. Nascimento, Gabriella A. Matos, Lianna C. Pereira, Anderson E.C.C.B. Mourão, Aline M. Sampaio, Reinaldo B. Oriá, Pierluigi Toniutto. Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review. Annals of Hepatology 2020; 19(1): 24 doi: 10.1016/j.aohep.2019.07.011
|
5 |
Antonella Sgura, Andrea De Amicis, Laura Stronati, Serena Cinelli, Francesca Pacchierotti, Caterina Tanzarella. Chromosome aberrations and telomere length modulation in bone marrow and spleen cells of melphalan‐treated p53+/− mice. Environmental and Molecular Mutagenesis 2008; 49(6): 467 doi: 10.1002/em.20405
|
6 |
Mohammed A. F. Elewa, Mohammed M. Al-Gayyar, Mona F. Schaalan, Khaled H. Abd El Galil, Mohamed A. Ebrahim, Mamdouh M. El-Shishtawy. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers. Clinical & Experimental Metastasis 2015; 32(5): 479 doi: 10.1007/s10585-015-9721-6
|
7 |
Deng-Fu Yao, Wei Wu, Min Yao, Li-Wei Qiu, Xin-Hua Wu, Xiao-Qin Su, Li Zou, Deng-Bing Yao, Xian-Yong Meng. Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(31): 4966-4972 doi: 10.3748/wjg.v12.i31.4966
|
8 |
Nitin Saini, Radhika Srinivasan, Yogesh Chawla, Sanjeev Sharma, Anuradha Chakraborti, Arvind Rajwanshi. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Liver International 2009; 29(8): 1162 doi: 10.1111/j.1478-3231.2009.02082.x
|
9 |
Cardin Romilda, Piciocchi Marika, Sinigaglia Alessandro, Lavezzo Enrico, Bortolami Marina, Kotsafti Andromachi, Cillo Umberto, Zanus Giacomo, Mescoli Claudia, Rugge Massimo, Farinati Fabio. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-177
|
10 |
Po-Shuan Huang, Chia-Siu Wang, Chau-Ting Yeh, Kwang-Huei Lin. Roles of Thyroid Hormone-Associated microRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma. International Journal of Molecular Sciences 2019; 20(20): 5220 doi: 10.3390/ijms20205220
|
11 |
Vito Sansone, Marco Le Grazie, Jenny Roselli, Simone Polvani, Andrea Galli, Francesco Tovoli, Mirko Tarocchi. Telomerase reactivation is associated with hepatobiliary and pancreatic cancers. Hepatobiliary & Pancreatic Diseases International 2020; 19(5): 420 doi: 10.1016/j.hbpd.2020.04.007
|
12 |
Ahmad Shariftabrizi, Mohammad Reza Khorramizadeh, Farshid Saadat, Kamran Alimoghadam, Farnaz Safavifar, Mohammad Reza Ebrahimkhani. Concomitant reduction of matrix metalloproteinase-2 secretion and intracellular reactive oxygen species following anti-sense inhibition of telomerase activity in PC-3 prostate carcinoma cells. Molecular and Cellular Biochemistry 2005; 273(1-2): 109 doi: 10.1007/s11010-005-8158-7
|